A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Trial Profile

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs TD 8954 (Primary) ; Metoclopramide
  • Indications Gastrointestinal motility disorders
  • Focus Adverse reactions
  • Sponsors Theravance
  • Most Recent Events

    • 16 Dec 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 31 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 21 Nov 2013 Planned initiation date changed from 1 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top